Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,839
Closed -$209K 455
2022
Q4
$209K Buy
+4,839
New +$191K 0.02% 399
2022
Q3
Sell
-4,955
Closed -$225K 438
2022
Q2
$225K Buy
4,955
+440
+10% +$20.7K 0.02% 389
2022
Q1
$215K Sell
4,515
-14,220
-76% -$602K 0.01% 456
2021
Q4
$772K Buy
+18,735
New +$706K 0.06% 123

Other funds holding EXC

American Trust's EXC Position: Q1 2023 in Review

American Trust sold out of Exelon (EXC) in Q1 2023, closing a stake of 4,839 shares — an estimated $209K sold.

American Trust first reported a position in EXC in Q4 2021 and held it in 4 quarters. The position peaked at $772K in Q4 2021. 999 funds tracked by Wall St. Rank hold EXC as of Q1 2023.

  • American Trust reported no remaining Exelon position as of Q1 2023 after selling out during the quarter.
  • American Trust sold 4,839 Exelon shares in Q1 2023, an estimated $209K.
  • American Trust first reported a position in Exelon in Q4 2021 and held it in 4 quarters.
  • American Trust's Exelon position peaked at $772K in Q4 2021.
  • 999 funds tracked by Wall St. Rank held Exelon as of Q1 2023.

Based on American Trust's 13F filing for Q1 2023, filed 22 May 2023.